VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HCI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HCIHCI Group, Inc.
$180.41$2.3B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksHCIQuarterly Financials

HCI Group, Inc. (HCI) Quarterly Financials

120+ quarters historyFree accessUpdated daily

HCI Group, Inc. (HCI) quarterly income statement — complete revenue, gross profit & net income history

HCI Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue242.88M246.24M216.4M221.95M217.06M161.44M175.24M206.35M206.42M162.66M131.54M127.34M128.48M115.93M125.39M125.4M125.27M110.87M97.61M99.96M
Revenue Growth %11.9%52.53%23.49%7.56%5.15%-0.75%33.22%62.05%60.67%40.31%4.9%1.55%2.56%4.56%28.46%25.45%33.11%57.65%46.88%23.97%
Medical Costs & Claims65.6M51.93M97.81M95.01M86.58M138.43M131.84M101.78M102.06M88.11M89.49M84.51M83.28M96.16M164.47M113.69M102.11M87.35M86M79.09M
Medical Cost Ratio %27.01%21.09%45.2%42.81%39.89%85.75%75.23%49.32%49.44%54.17%68.04%66.37%64.83%82.95%131.17%90.66%81.51%78.79%88.11%79.12%
Gross Profit177.28M194.32M118.6M126.94M130.48M23.01M43.4M104.58M104.36M74.54M42.04M42.83M45.19M19.76M-39.08M11.71M23.16M23.52M11.61M20.87M
Gross Margin %72.99%78.91%54.8%57.19%60.11%14.25%24.77%50.68%50.56%45.83%31.96%33.63%35.17%17.05%-31.17%9.34%18.49%21.21%11.89%20.88%
Gross Profit Growth %35.87%744.53%173.28%21.39%25.03%-69.13%3.22%144.17%130.93%277.17%207.58%265.88%95.12%-15.97%-436.69%-43.91%-8.44%55.51%2203.17%-24.91%
Operating Expenses61.9M50.32M28M32.55M30.14M17.12M29.32M28.55M26.93M20.38M21.96M22.56M22.05M17.02M24.52M23.27M19.16M20.98M18.11M15.77M
OpEx / Revenue %25.48%20.43%12.94%14.67%13.89%10.6%16.73%13.84%13.05%12.53%16.69%17.72%17.17%14.68%19.55%18.55%15.29%18.92%18.56%15.78%
Depreciation & Amortization02.34M2.32M4.54M2.02M2.19M2.16M-1.05M1M1.98M1.97M2M2.23M2.35M2.16M1.98M1.52M1.27M1.35M1.56M
Combined Ratio %52.49%41.52%58.13%57.47%53.77%96.35%91.97%63.16%62.49%66.7%84.73%84.08%81.99%97.63%150.72%109.22%96.81%97.71%106.66%94.9%
Operating Income115.38M144M90.6M94.39M100.34M5.89M14.08M76.03M77.43M54.16M20.09M20.27M23.14M2.74M-63.6M-11.56M4M2.54M-6.5M5.1M
Operating Margin %47.51%58.48%41.87%42.53%46.23%3.65%8.03%36.84%37.51%33.3%15.27%15.92%18.01%2.37%-50.72%-9.22%3.19%2.29%-6.66%5.1%
Operating Income Growth %14.99%2344.41%543.46%24.16%29.59%-89.12%-29.91%275.14%234.67%1874.48%131.58%275.31%478.26%8.08%-877.89%-326.8%-60.39%-12.84%-130.2%-56.89%
EBITDA116.31M146.34M92.92M98.93M102.36M8.08M16.24M74.98M78.43M56.14M22.06M22.27M25.37M5.09M-61.44M-9.58M5.52M3.81M-5.16M6.66M
EBITDA Margin %47.89%59.43%42.94%44.57%47.16%5%9.27%36.33%38%34.52%16.77%17.48%19.74%4.39%-49%-7.64%4.4%3.44%-5.28%6.66%
Interest Expense923K1.01M1.02M3.74M3.38M3.26M3.42M3.45M3.15M2.82M2.83M2.67M2.8M2.71M2.81M1.51M601K657K1.66M2M
Non-Operating Income-923K-1.01M-1.02M-3.74M-3.38M-3.26M-3.42M-3.45M-3.15M-2.74M-2.83M-2.67M-2.8M-2.71M-2.81M-1.51M-601K-559K-1.66M-2M
Pretax Income115.38M144M90.6M94.39M100.34M5.89M14.08M76.03M77.43M54.16M20.09M20.27M23.14M2.74M-63.6M-11.56M4M2.54M-6.5M5.1M
Pretax Margin %47.51%58.48%41.87%42.53%46.23%3.65%8.03%36.84%37.51%33.3%15.27%15.92%18.01%2.37%-50.72%-9.22%3.19%2.29%-6.66%5.1%
Income Tax30.34M36M22.71M24.11M26.11M1.76M4.69M18.93M20.47M13.25M4.42M5.38M5.34M92K-12.1M-3.02M1.21M1.1M-1.64M1.27M
Effective Tax Rate %26.3%25%25.07%25.55%26.02%29.83%33.3%24.9%26.44%24.46%22%26.57%23.09%3.35%19.02%26.11%30.24%43.46%25.15%24.86%
Net Income73.41M97.65M65.51M66.16M69.68M2.58M5.68M54.08M47.61M38.1M13.16M12.44M15.34M1.53M-50.96M-9.98M903K33K-6.3M1.92M
Net Margin %30.22%39.66%30.27%29.81%32.1%1.6%3.24%26.21%23.07%23.42%10%9.77%11.94%1.32%-40.64%-7.96%0.72%0.03%-6.45%1.92%
Net Income Growth %5.34%3679.18%1052.89%22.35%46.36%-93.22%-56.81%334.59%210.41%2396.46%125.82%224.67%1598.56%4524.24%-709.39%-620.66%-85.31%-98.78%-140.91%-78.55%
EPS (Diluted)6.608.384.905.185.350.200.524.243.813.391.341.281.540.32-6.11-0.950.290.01-0.780.24
EPS Growth %23.36%4090%842.31%22.17%40.42%-94.1%-61.19%231.25%147.4%959.38%121.93%234.74%431.03%--683.33%-495.83%-61.33%-97.34%-145.88%-77.78%
EPS (Basic)7.469.475.055.576.470.220.545.184.764.311.531.451.780.32-6.12-0.950.290.01-0.790.25
Diluted Shares Outstanding12.88M12.88M12.88M12.88M12.69M12.69M10.51M12.7M12.62M11.45M10.97M10.92M10.86M8.36M8.43M9.02M9.77M9.99M8.02M7.95M